Alaa Gamal – Senior Executive & Regional Pharma…
When it comes to knowledge of the Middle East and Africa region’s pharmaceutical industry, few executives have the experience of Dr Alaa Gamal.…
Tagged with Pfizer
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab Import…
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for…
The bright future of mRNA technology – InConversation…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…
India: 200% Pharma Sector Budget Boost; 3x Industry Growth in…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in the latest national budget;…
Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…
Viatris: Cost-Cutting Needed at New Generics Behemoth
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…
Top 4 Global Vaccine Companies
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…
Sissel Lønning Andresen – Country Manager & Internal…
Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years, what other Pfizer affiliates can…
Thomas D. Madden – CEO, Acuitas Therapeutics
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…
PharmaBoardroom Most Read Interviews of 2020
The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the past year. From Mexico to Morocco…
Chinese Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of successful COVID-19 trial results from…
Bayer Strategy Head: Big Pharma “Needs to Up its Game”
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech executives spoke about the changing…
